Aim To investigate a potential of the clinical use of the soluble fms-like tyrosine kinase 1 (sFLT-1) to placental growth factor (PlGF) ratio from the perspective of a small hospital centre. Methods Maternal serum samples were analysed at 24 1/7-28 0/7 , and 28 1/7-32 0/7 weeks of gestation. The level of sFLT-1 and PIGF was determined by immunoassa...

By Andrijana Müller, Vesna Horvat, Martina Vulin, Sanja Mandić, Vatroslav Šerić, Domagoj Vidosavljević